InsidersTradesSigma
Total declarations
Company
▲ Purchases (6 ops.)
▼ Sales (0 ops.)
Browse the complete record of transactions filed by MILBY RANDY, Chairman & CEO. Insider active across 1 companies, notably Hillstream BioPharma Inc.. In total, 13 disclosures have been published. Total volume traded: €2k. The latest transaction was filed on 17 June 2022 (Acquisition). Regulator: SEC (Form 4). The full history is accessible without signup.
Declarations13 total
€370500 shares@ €0.73950.1% of flow
Common Stock
SEC:0001493152-22-017377:0·
Ideal exit: 14 Mar 2023 (T+270)
€150234 shares@ €0.64060.1% of flow
Common Stock
SEC:0001493152-22-016088:0·
Ideal exit: 3 Mar 2023 (T+270)
€11 shares@ €0.88230.0% of flow
Common Stock
SEC:0001493152-22-015724:0·
Ideal exit: 26 Feb 2023 (T+270)
€144200 shares@ €0.72050.1% of flow
Common Stock
SEC:0001493152-22-015080:0·
Ideal exit: 19 Feb 2023 (T+270)
€421500 shares@ €0.84130.1% of flow
Common Stock
SEC:0001493152-22-014792:0·
Ideal exit: 14 Feb 2023 (T+270)
€433500 shares@ €0.86520.2% of flow
Common Stock
SEC:0001493152-22-014500:0·
Ideal exit: 13 Feb 2023 (T+270)
€2,2067,575 shares@ €0.29120.8% of flow
Common Stock
SEC:0001493152-22-010294:0·
€22,6268,101 shares@ €2.7937.9% of flow
Common Stock
SEC:0001493152-22-001680:0·
€22,6268,101 shares@ €2.79316.0% of flow
Common Stock
SEC:0001493152-22-001680·
€76,75027,479 shares@ €2.79354.4% of flow
Common Stock
SEC:0001493152-22-001674·
€41,73314,942 shares@ €2.79329.6% of flow
Common Stock
SEC:0001493152-22-001677·
€41,73314,942 shares@ €2.79314.6% of flow
Common Stock
SEC:0001493152-22-001677:0·
€76,75027,479 shares@ €2.79326.8% of flow
Common Stock
SEC:0001493152-22-001674:0·
13 of 13 declarations
About MILBY RANDY
Randy Milby is Chief Executive Officer at Hillstream BioPharma Inc. In this role, he leads the operations and strategy of the company, which focuses on developing innovative treatments. His expertise in biopharmaceuticals is essential to guide the company towards sustainable growth.
